![Daniel M. Jorgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel M. Jorgensen
Directeur Technique/Scientifique/R&D chez
Ocugen OpCo, Inc.
Profil
Daniel M.
Jorgensen currently works at Ocugen OpCo, Inc., as Chief Medical Officer from 2017.
Dr. Jorgensen also formerly worked at Critical Path Institute, as Chief Executive Officer from 2022 to 2024, PolyMedix, Inc., as Chief Medical Officer & SVP-Clinical Development, Centers for Disease Control & Prevention, as Epidemic Intelligence Service Officer, Innovation Pharmaceuticals, Inc., as Chief Medical Officer from 2015 to 2016, SANUWAVE Health, Inc., as Chief Medical Officer, Finch Research & Development LLC, as Chief Medical Officer from 2016 to 2017, and Ocugen, Inc., as Chief Medical Officer from 2017 to 2020.
Dr. Jorgensen received his graduate degree from the University of Washington, undergraduate degree and Masters Business Admin degree from Yale University, and doctorate degree from the University of Wisconsin.
Postes actifs de Daniel M. Jorgensen
| Sociétés | Poste | Début |
|---|---|---|
Ocugen OpCo, Inc. | Directeur Technique/Scientifique/R&D | 01/04/2017 |
Anciens postes connus de Daniel M. Jorgensen
| Sociétés | Poste | Fin |
|---|---|---|
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Directeur Général | 09/01/2024 |
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | 15/07/2020 |
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Technique/Scientifique/R&D | 01/04/2017 |
| INNOVATION PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 01/03/2016 |
Centers for Disease Control & Prevention
 Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Corporate Officer/Principal | - |
Formation de Daniel M. Jorgensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Government |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
Innovation Pharmaceuticals, Inc.
 Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases | Health Technology |
SANUWAVE Health, Inc.
 SANUWAVE Health, Inc. Medical SpecialtiesHealth Technology Operates as a shockwave technology company using noninvasive, high energy, acoustic shockwaves for regenerative medicine and other applications | Health Technology |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
